Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain AMWL Q1 2026 Earnings NarrowerThanExpected Loss Sends Shares Higher NEPH Q1 2026 Earnings Narrow EPS Miss Triggers Modest Selloff Encore Capital Group ECPG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency FHN Q1 2026 Earnings EPS Beats Estimates by 623 as Stock Edges Higher VPG Q1 2026 Earnings EPS Surprise Drives DoubleDigit Stock Gain